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Copper(II) Coordination Abilities of the Tau Protein’s N-
Terminus Peptide Fragments: A Combined Potentiometric,
Spectroscopic and Mass Spectrometric Study
Márton Lukács,[a] Györgyi Szunyog,[a] Ágnes Grenács,[a] Norbert Lihi,[a, b] Csilla Kállay,[a]
Giuseppe Di Natale,[c] Tiziana Campagna,[c] Valeria Lanza,[c] Giovanni Tabbi,[c]
Giuseppe Pappalardo,[c] Imre Sóvágó,[a] and Katalin Várnagy*[a]
Copper(II) complexes of the N-terminal peptide fragments of
tau protein have been studied by potentiometric and various
spectroscopic techniques (UV-vis, CD, ESR and ESI-MS). The
octapeptide Tau(9-16) (Ac@EVMEDHAG@NH2) contains the H14
residue of the native protein, while Tau(26-33)
(Ac@QGGYTMHQ@NH2) and its mutants Tau(Q26K-Q33K)
(Ac@KGGYTMHK@NH2) and Tau(Q26K-Y29A-Q33K)
(Ac@KGGATMHK@NH2) include the H32 residue. To compare the
binding ability of H14 and H32 in a single molecule the
decapeptide Ac@EDHAGTMHQD@NH2 (Tau(12-16)(30-34)) has
also been synthesized and studied. The histidyl residue is the
primary metal binding site for metal ions in all the peptide
models studied. In the case of Tau(9-16) the side chain
carboxylate functions enhance the stability of the M@Nim
coordinated complexes compared to Tau(26-33) (logK(Cu@Nim)
=5.04 and 3.78, respectively). Deprotonation and metal ion
coordination of amide groups occur around the physiological
pH range for copper(II). The formation of the imidazole- and
amide-coordinated species changes the metal ion preference
and the complexes formed with the peptides containing the
H32 residue predominate over those of H14 at physiological pH
values (90%–10%) and in alkaline samples (96%–4%).
Introduction
Tau protein is an intrinsically disordered large protein consisting
of 441 amino acids including 12 histidyl residues as potential
metal binding sites.[1] The biological role of tau protein is
associated with its interaction with tubulins to promote their
assembly into microtubules and to stabilize the microtubules.[2,3]
Many recent studies suggest that in addition to amyloid-β, tau
protein may also play a significant role in the development of
Alzheimer’s disease and/or other neurodegenerative
disorders.[4,5] The neuropathological hallmarks of these diseases
are related to the accumulation of amyloid-β into senile plaques
and of hyperphosphorylated tau into neurofibrillary tangles.[6,7]
Moreover, huge number of recent publications support that
metal ions also play a crucial role in neurodegeneration.[8] The
interactions of metal ions with prion protein and its peptide
fragments and with amyloid-β peptide have been extensively
studied and the most important results are summarized in
several reviews.[9–16] On the contrary, the association of metal
ions with tau protein and its various peptide fragments are
much less studied and the results are partly contradictory. It is
widely accepted that the aggregation and toxic deposition of
tau protein is triggered by hyperphosphorylation of the peptide
and this process is significantly influenced by various metal
ions.[17] The extent of aggregation of the protein is affected by
the concentration and also by the oxidation state of the metal
ions[18–20] and the role of the copper or iron catalyzed redox
reactions has also been reported.[21] These previous studies
strongly support the involvement of metal ions in the formation
of neurofibrillary tangles but the exact characterization of the
metal binding sites has not been satisfactorily clarified.[8,22]
Imidazole-N donors of histidine are effective metal binding
sites of proteins[23,24] and tau protein is relatively rich in this
residue. Tau protein sequence also shows some methionine
residues especially in the N-terminal domain. These amino acids
are, however, rather far from each other in the sequence of the
protein and, as a consequence, any of them may be considered
as a potential binding site. On the other hand, the microtubule-
binding region of tau contains three or four pseudorepeats,
each of them has 31–32 amino acid residues including a highly
conservative octadecapeptide domain which begins with valine
and ends with the PGGG sequence but involves also histidine.
The influence of copper(II) ions on the aggregation processes of
several fragments from this domain of the protein has already
been studied but the exact nature of the metal binding modes
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has not been elucidated.[25–27] Saxena et al. used ESR spectro-
scopy to investigate a series of peptides from this domain and a
high similarity in the binding modes of the octadecapeptides
has been suggested with involvement of imidazole-N and the
backbone amide-N in copper binding.[28]
In almost all previous complexation studies the peptide
fragments of the microtubule-binding domain were investi-
gated, although histidines are also present in the N-terminal
region of the protein. Moreover, a comprehensive mass
spectrometry screening on cerebrospinal fluid samples of
patients with Alzheimer disease revealed an increased level of
peptide fragments from the N-terminal region.[29] This observa-
tion promoted a recent circular dichroism and ESI-MS study on
the copper(II) complexes of two peptides encompassing the 1–
25 and 26–44 residues of human tau protein.[30] This study
undoubtedly proved that the N-terminal domain of tau protein
can also effectively bind copper(II) ions and the terminal amino
and/or histidyl imidazole nitrogen atoms were suggested as the
primary metal binding sites. This paper gave also useful
indication about the stoichiometry of the copper(II) complexes.
On the other hand, the complete metal complex speciation by
potentiometry was not attempted because of the complexity of
the system (many pK values in overlapping processes may
prevent obtaining of reliable stability constant values) and
potential solubility problems of the copper(II) complexes.
In the present paper we selected the putative metal binding
site of each peptide and carried out the potentiometric
measurements for reliable stability constant values. These
values would be useful for the subsequent studies using the
longer parent peptides. We report the results of a comprehen-
sive study on the copper(II) complexes of two peptide frag-
ments and their various mutants from the N-terminal region of
human tau protein. The octapeptide Tau(9-16)
(Ac@EVMEDHAG@NH2) contains H14 residue of the native
protein. Another octapeptide Tau(26-33) (Ac@QGGYTMHQ@NH2)
provide information on the binding ability of H32 residue of the
native protein. The solubility of this peptide is rather low in
aqueous media thus the glutamine/lysine mutant has also been
synthesized and studied (Tau(Q26K-Q33K),
Ac@KGGYTMHK@NH2). The understanding of the observed
differences in the metal binding ability of Tau(9-16) and Tau(26-
33) made also necessary the synthesis of a Tyr/Ala mutant (Tau
(Q26K-Y29A-Q33K), Ac@KGGYTMHK@NH2). Finally, to compare
the binding ability of H14 and H32 in a single molecule, a
model decapeptide Tau(12-16)(30-34) (Ac@EDHAGTMHQD@NH2)
has also been synthesized and studied.
Results and Discussion
Protonation Equilibria of the Peptides
Protonation constants of the peptides have been determined
by potentiometric measurements and the data are listed in
Table 1. It is clear from the Table that the number of the
protonation sites is different for each ligand and their charges
are also varying depending on the number of carboxylate
functions. In general, the deprotonation steps generally signifi-
cantly overlap thus making difficult the exact assignment of the
pK values to specific side chains. Comparison of these values
with the pK values of previously studied peptides, however,
provides a good estimation for this question. In the case of Tau
(9-16) the imidazole of histidine is the most basic site, while the
deprotonations of the carboxylic groups of glutamyl and
aspartyl residues occur in the slightly acidic pH range. The pK
values for the histidyl residue of terminally protected
peptides[31] are generally lower than that of Tau(9-16) but the
small shift towards the alkaline region can be easily explained
by the negative charges of the three carboxylate groups. The
pK values of Tau(26-33) have been determined in very diluted
samples because of the low solubility of the ligand but it is
evident that the highest pK value belongs to the tyrosyl
phenolic-OH. The mutant with two lysyl residues
(Ac@KGGYTMHK@NH2) has four protonation sites and the lysyl
amino groups are the most basic sites. Similar observation is
obtained for the Tyr/Ala mutant but the absence of the
phenolate group results in a slightly increased difference in the
basicities of the two amino groups of lysines. The decapeptide
Ac@EDHAGTMHQD@NH2 has five protonation sites and the
highest two values belong to the 2 histidyl residues. It can also
be observed that the presence of two histidines slightly
increases the acidity of the carboxylic functions, while the
basicity of imidazole increases as compared to other 2-histidine
peptides.[32] All the peptide ligands were also screened for pH
dependent conformational changes. To do this, far UV-CD
spectra of the free peptides were recorded at pH 7.0 and 10.0
(4–10 pH range) and a selection of these spectra are shown in
Figure S1 in the Supporting Information. Peptide conformation
Table 1. Protonation constants of the peptides (T=298 K, I=0.2 M).
Species Tau[9-16]
[Ac@EVMEDHAG@NH2]
Tau[26-33]
[Ac@QGGYTMHQ@NH2]
Tau[Q26K-Q33K]
[Ac@KGGYTMHK@NH2]
Tau[Q26K-Y29A-Q33K]
[Ac@KGGATMHK@NH2]
Tau[10-14][30-34]
[Ac@EDHAGTMHQD@NH2]
[HL] 6.70(1) 9.48(5) 10.71(3) 10.77(1) 7.12(1)
[H2L] 11.38(2) 15.50(10) 20.84(2) 20.70(2) 13.39(1)
[H3L] 15.52(2) – 30.22(4) 26.88(2) 17.87(2)
[H4L] 18.93(4) – 36.44(4) – 21.72(2)
[H5L] – – – – 24.93(4)
pK1 6.70 9.48 10.71 10.77 7.12
pK2 4.68 6.02 10.13 9.93 6.27
pK3 4.14 – 9.38 6.18 4.48
pK4 3.41 – 6.22 – 3.85
pK5 – – – – 3.21
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was slightly affected by the different pH values as demon-
strated by a strong negative ellipticity observed at 200 nm in all
cases. This suggests that the peptide fragments always adopt a
disordered structure in solution.
Copper(II) Complexes of the Tau(9-16) Fragment
Stability constants of the copper(II) complexes were obtained
from the computer evaluation of potentiometric titrations and
the data are collected in Table 2 together with the UV-vis, CD
and ESR spectral parameters of the major species.
Figure 1 shows the metal ion speciation of the -copper
(II)@Tau(9-16) system.
Both thermodynamic and spectral data reveal a good
agreement in the complex formation processes of Tau(9-16)
and other terminally protected peptides containing one internal
histidyl residue, e.g. the various peptide fragments of prion
protein outside the octarepeat domain.[20,22] According to the
spectral data, the first two species ([CuHL] and [CuL]@)
correspond to the coordination of the imidazole side chain but
the equilibrium constant calculated for the Cu@Nim binding is
slightly higher than the values obtained for the various prion
fragments. The stability constants for a simple imidazole
coordination is generally around log K=4.0�0.2.[34] The
stability enhancement of Tau(9-16) peptide can be easily
explained by the contribution of the side chain carboxylate
functions of the aspartyl and/or glutamyl residues. ESR spectra
of copper(II)@Tau(9-16) system in the 5–6.5 pH range showed
the presence of two different species (Figure S2 in the
Supporting Information). The spectrum at pH 6.2 was satisfac-
torily simulated by using two set of Hamiltonian parameters.
The first parameter set (g j j=2.344, A j j=148×10
@4 cm@1) can
be assigned to the [CuHL] species and it is consistent with a
histidine nitrogen atom coordinating copper(II) ion.[35] In
addition, the lowering of the g-value and the rising of the A-
value is a reliable suggestion for coordinating carboxylate
which assists histidine moiety ([CuL]@ species).[36]
It is also a common feature of the one-histidine peptides
that the deprotonation of the first two amide residues takes
place in a cooperative process resulting in the (Nim,N
@,N@)
coordination mode of [CuH-2L]
3@ which is the dominating
species in the physiological pH range. This N3O coordination
environment, corresponding to [CuH-2L]
3@ species, is also
inferred by Hamiltonian parameters drawn from ESR spectra run
in the 7–8.5 pH range, i. e. g j j=2.239, A j j=163×10
@4 cm@1
(Table 2). [CuH-3L]
4@ is formed in the alkaline samples and its
spectral and thermodynamic parameters are very similar to
those of other 4 N copper(II) complexes with (Nim,N
@,N@,N@)
coordination mode.[31,33–34] The ESR parameters of [CuH-3L]
4@
species are assigned to a four-nitrogen in plane, although an
higher absolute value of A j j would have been expected. The
value obtained can be explained by considering a small
deviation of the coordinating atoms from the planarity, which is
also supported by the fairly high ɛ value for this species
(Table 2).
The addition of two equivalents of copper(II) to Tau(9-16)
produce little precipitation phenomena as the pH was raised to
mild acidic values. ESR spectra at pH values lower than 7
showed mainly the features of copper(II) hexaaqua ion. Starting
from pH 7.6 the same parameters for the [CuH-2L]
3@ species
described for 1 :1 Cu(II)@Tau(9-16) system were recorded. It is
clear that Tau(9-16) can coordinate one metal ion only,
Table 2. Stability constants and spectral data of the copper(II) complexes of the octapeptide Tau(9-16) (T=298 K, I=0.2 M KCl).
Species Log βpqr Visible spectra CD spectra ESR
λmax [nm] [ɛ [M@1cm@1]] λmax [nm] [Δɛ [M@1cm@1]] g j j A j j [104×cm@1]
[CuHL] 9.66(17) – – 2.344 148
[CuL]@ 5.04(7) 747 (38) (wide) – 2.315 160
[CuH-2L]
3@ @8.09(7) 616 (74) 651(+0.34)
557(+0.40)
339(@0.23)
246(+7.13)
2.239 163
[CuH-3L]
4@ @16.61(11) 530 (144) 627(+1.05)
498(@1.21)
329(+1.20)
295(@0.97)
260(+7.39)
2.194 200
log K(Cu@Nim) 5.04
pK12(amide) 6.57
pK3(amide) 8.52
Figure 1. Concentration distribution curves of the major species formed in
the copper(II)@Tau(9-16) system (c(L)=c(Cu2+)=1 mM).
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although a little clue of a weak site can be seen from the ESR
spectrum obtained at pH 7.6. Beside the ESR parameters
corresponding the [CuH-2L]
3@ species, a careful simulation of
this spectrum (Figure S3 in the Supporting Information) gave
Hamiltonian parameters (g j j=2.279, A j j=179×10
@4 cm@1) sim-
ilar to those found for another histidine containing peptide
coordinating by imidazole nitrogen and amide nitrogen atoms
with the involvement of a carboxylate moiety.[37]
Copper(II) Complexes of Tau(26-33) and Related Peptides
Stability constants of the copper(II) complexes of the octapep-
tides Tau(26-33) and its Gln/Lys and Tyr/Ala mutants are
included in Table 3.
The speciation curves for the Gln/Lys mutant
(Ac@KGGYTMHK@NH2) are shown by Figure 2. The correspond-
ing concentration distribution diagrams of the other two
peptide complexes are included in the Supporting Information
(Figures S4 and S5). At the first sight, the comparison of Figure 1
with Figure 2 (or with Figures S4 or S5) suggests a high
complexity in the complex formation processes of the (26-33)
mutants.
This is, however, misleading because the high number of
different stoichiometries in the alkaline pH range comes from
the deprotonation of the non-coordinated lysyl and/or tyrosyl
residues. These side chains are generally not metal binding sites
in peptide complexes if other strongly coordinating groups (like
histidine) are also present in the molecules.[23] As a conse-
quence, the stoichiometry of the same coordination modes can
be different due to the presence or absence of the Lys and/or
Tyr residues. For example, the Cu@Nim coordination mode
corresponds to three different stoichiometries, CuH3L, CuH2L
and CuHL for Ac@KGGYTMHK@NH2, Ac@KGGATMHK@NH2 and
Ac@QGGYTMHK@NH2, respectively. Taking into account this
effect of the tyrosyl and lysyl residues the number of the major
species is the same for the Tau(9-16) and Tau(26-33) fragments.
The overall stability of the complexes and especially their
spectral characteristics are, however, significantly different
suggesting important differences in the metal binding ability
and binding modes of the various fragments. All spectroscopic
data for the major species of the copper(II)@Tau(26-33) and
related systems are included in Table S1 in the Supporting
Information.
Thermodynamic and spectroscopic data unambiguously
prove that imidazole-N donor atoms are the primary or
anchoring sites in all peptide complexes. The stability constants
of the corresponding species are around 4.0 log units (see
Table 3) which corresponds well the literature data,[34] but much
smaller than it was obtained for the Tau(9-16) fragment
(Table 2), due to the absence of the negatively charged
carboxylate functions.
Deprotonation and coordination of the first two amide
groups takes place in a cooperative manner resulting in the
formation of the (Nim,N
@,N@) coordination mode.
This process was observed for the Tau(9-16) fragment in
analogy to many other peptides containing internal histidyl
residues. However the thermodynamic and spectral data of Tau
(26-33) and its mutants are significantly different from those of
Tau(9-16). The pK values for the amide deprotonation are
significantly lower for the Tau(26-33) complexes suggesting an
extra-stabilization in the corresponding species.
ESR spectra run on frozen solutions of Cu(II)@Tau(26-33) and
Cu(II)@Tau(Q26K-Q33K) systems at pH around neutrality gave
Table 3. Stability constants of the copper(II) complexes of Tau(26-33) and its mutants (T=298 K, I=0.2 M KCl).
Species Tau[26-33]
[Ac@QGGYTMHQ@NH2]
Tau[Q26K-Q33K]
[Ac@KGGYTMHK@NH2]
Tau[Q26K-Y29A-Q33K]
[Ac@KGGATMHK@NH2]
[CuH3L] – 34.15(3) –
[CuH2L] – – 25.18(3)
[CuHL] 13.26(14) 23.98(9) –
[CuL] – 16.01(2) 14.77(2)
[CuH-1L] 3.23(5) 6.68(2) 6.78(3)
[CuH-2L] @5.60(9) @3.58(2) @3.19(4)
[CuH-3L] @15.47(8) @14.09(1) @13.67(4)
log K(Cu@Nim) 3.78 3.93 4.48
pK12(amide) 5.01 5.09 5.21
pK3(amide) 8.83 7.97 7.99
pK(Tyr@OH) 9.87 9.33 –
pK(LysNH3
+) – 10.26 9.97
pK(LysNH3
+) – 10.51 10.48
Figure 2. Concentration distribution curves of the major species formed in
the copper(II)@Ac@KGGYTMHK@NH2 system (c(L)=c(Cu2+)=1 mM).
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Hamiltonian parameters in agreement with the three-nitrogen
coordination for [CuH-1L] and [CuHL] species (Figure S6 in the
Supporting Information). These values are g j j=2.214, A j j=
191×10@4 cm@1 and g j j=2.221, A j j=191×10
@4 cm@1 for -Cu
(II)@Tau(26-33) and Cu(II)@Tau(Q26K-Q33K) systems, respec-
tively. The A j j value obtained for both systems at neutral pH is
higher than would be expected for an N3O coordination
environment. Additional information comes from d-d band
wavelength (590 nm for both species) which is blue-shifted of
about 20 nm than expected for a (Nim,N
@,N@) coordination
mode. A wide range of studies carried out on Cu(II) binding to a
variety of oligopeptides containing methionine residues re-
vealed the possibility of S!Cu(II) interactions and distinct band
for CD spectra in the region 320–330 nm can be observed.
Indeed starting from moderate acidic pH a charge transfer (CT)
band at about 330 nm is visible in the CD spectra, but it results
to be embedded in the CT band of coordinating amides at
neutral pH (328 nm). On the light of these clues, involvement of
the sulphur methionine atom in the coordination plane can be
inferred.[38] As the pH is brought to alkaline values an additional
amide nitrogen atom deprotonates and replaces the sulphur
atom (Nim,N
@,N@,N@). This coordination environment change
causes a strong blue-shift of the d-d band wavelength, the
lowering of the g j j-values as well as a significant increment of
the absolute A j j-values (Table S1).
The enhanced stability of the (Nim,N
@,N@) coordination mode
in the Cu(II)@Tau(26-33) system was supported by far-UV CD
investigations. In particular, the far-UV CD spectra of Tau
peptides are characterised by a strong negative band below λ=
200 nm, typical of peptides in a random-coil conformation
(Figure S1). The reduction of the negative ellipticity centred
below λ=200 nm in the presence of equimolar copper(II) ion,
suggests a structuring effect of the metal ion within the
polypeptide backbone (Figure S7) as a function of the increas-
ing pH value. A clearer evidence of the metal induced
conformational changes is provided by subtracting the apo-
peptide CD curve profile at the same pH value from the
corresponding CD spectra obtained in the presence of -copper
(II). The resulting difference CD spectra profile of the Cu(II)@-Tau
(26-33) system reveals the appearance of a positive band
centred around λ=190–200 nm and a negative band centred
around λ=210–220 nm at pH 7 (Figure S7a). This well-defined
CD-curve profile has been already reported in our previous
works and is indicative of conformational changes mainly
related to the copper(II) coordination by imidazole side chain of
histidine residue and the amide nitrogens.[27] Interestingly, the
different far-UV CD spectra of the Cu(II)@Tau(26-33) system
reveal the appearance of this distinctive CD band profile at
lower pH (pH 5–6) than those reported in the Cu(II)@Tau(9-16)
system thereby suggesting an enhanced stability of the
(Nim,N
@,N@) coordination mode in the former metal-peptide
system.
The spectral parameters of the Tau(26-33) fragment and its
Gln/Lys and Tyr/Ala mutants are rather similar to each other
and this also holds for thermodynamic data if the different
numbers of the non-coordinated side chains are taken into
account. This observation strongly supports that neither lysyl
nor tyrosyl residues take part in metal ion coordination. The
aforementioned spectral evidence strongly supports that extra-
stabilization of the copper(II) complexes of Tau(26-33) frag-
ments comes from the different binding mode of the com-
plexes. Figure 3 shows the speciation of a model system in
which the copper(II) ion and the peptides Tau(9-16) and the Lys
mutated Tau(26-33) are present in equimolar concentrations. It
is clear from this Figure that there is slight preference for
binding to His14 in slightly acidic media. The involvement of
the (Nim,N
@,N@,Smet) donor atoms in copper binding, however,
reverses this tendency and His32 becomes the primary binding
site of the peptide in neutral and alkaline samples.
Copper(II) Complexes of the Decapeptide
Ac@EDHAGTMHQD@NH2
The potentiometric and spectroscopic results obtained for the
binary complexes revealed that copper(II) binding to the
peptide fragments including His32 residue is favoured over
His14. This conclusion was, however, obtained from measure-
ments performed with small peptides containing only one
histidine, while the protein contains all possible metal binding
sites. A good model for the comparison of the metal binding
ability can be obtained if the specific sequences around His14
and His32 sites are connected in one terminally protected
peptide molecule. The decapeptide Ac@EDHAGTMHQD@NH2
has been synthesized and it contains the 12–16 residues
(EDHAG) linked to the 30–34 residues (TMHQD). The equilibrium
data and spectroscopic parameters of the decapeptide are
included in Table 4. The corresponding speciation curves are
plotted in Figures 4.a and 4.b at 1 :1 and 2 :1 metal to ligand
ratios, respectively.
pH-dependent CD spectra of the 1 :1 system (see Figure S8
in the Supporting Information) reveal that amide coordinated
species are not formed below pH 6.0. As a consequence, the
imidazole-N and carboxylate-O donors are the possible binding
sites in the complexes [CuH2L]
2+, [CuHL]+ and [CuL]. The
protonated species are present in rather low concentration and
Figure 3. Concentration distribution of copper(II) ion in a model system
containing copper(II) and the peptides Tau(9-16) and Tau(Q26K-Q33K)
mutants in equimolar concentration (c=1 mM).
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it rules out the exact assignment of the binding sites. [CuL] is
the major species between pH 5–7 and its stoichiometry
strongly supports the involvement of both imidazole moieties
in copper(II) binding. The stability constant is, however,
significantly higher than those reported for other 2Nim coordi-
nated complexes, which are generally around 5–6 log units. The
value (log K=7.66) in Table 4 unambiguously indicates that the
carboxylate residues also contribute to the metal binding in this
species. Further confirmation for this coordination environment
comes from the ESR spectrum at pH 5.8 showing a minor
percentage of [CuH-2L]
2@ (which was subtracted from the
spectrum) and the main [CuL] features, characterized by g j j=
2.295, A j j=176×10
@4 cm@1 which are typical of a chromophore
formed by two imidazole nitrogen atoms and a deprotonated
carboxylate as previously reported.[40,41]
Deprotonation and metal ion coordination of the first two
amide groups occur in a cooperative process resulting in the
formation of [CuH-2L]
2@. The protonation constant for this
reaction is pK12=6.71, while 6.57 and 5.01 were obtained for
the same process with the Tau(9-16) and Tau(26-33) fragments,
respectively (see Tables 2 and 3). These data may support the
preference of copper(II) binding to the histidine close to the
amino terminus (modelling the His14 residue) but the compar-
ison of CD parameters led to the opposite conclusion (see
Table 4 and Table S1).
This dichotomy can be resolved if one takes into account
the effect of the macrochelation of the two histidines. The
enhanced stability of the [CuL] shifts the coordination of the
amide groups into a higher pH range but the preference for
copper(II) binding to His32 above pH 7.0 remains intact. Of
course, two coordination isomers of [CuH-2L]
2@ can exist in
solution in which the coordination start from the His14 or His32
residues but comparison of the UV-vis and CD spectra strongly
support that the ratio of the latter binding mode is more than
90%. According to this hypothesis, the far-UV CD spectra of
-Tau(12-16)(30-34), were characterised by a strong negative
band below λ=200 nm (Figure S1). Changes upon addition of
the metal ion at 1 :1 metal to peptide ratio (Figure S9a) were
observed showing a reduction of the negative ellipticity at λ=
200 nm at pH 5–6. Interestingly, the different spectra obtained
at pH 5 and pH 6 (Figure S9, Inset) appear quite different from
those observed in Cu(II)@Tau(9-16) and Cu(II)@Tau(26-33) sys-
tems, when the (Nim,N
@,N@) binding mode is favoured as
suggested by potentiometric and spectroscopic results, reveal-
ing a different coordination mode of copper(II). The observed
CD profiles are reminiscent of those reported for copper(II)
complexes of prion peptide fragments when macrochelate
complex species form.[39]
Moreover, the far-UV CD spectra of Cu(II)@Tau(12-16)(30-34),
recorded at higher pH values (Figure S9a, pH range 7–10)
revealed the presence of a growing negative band around λ=
220 nm and a small positive band centred at λ=250 nm. Similar
variations in the CD-band profiles were also found for the
copper(II) complexes of the peptide fragments Tau(26-33)
suggesting the preference for copper(II) binding at His32 sites
at 1 : 1 metal to peptide ratio and basic pH values.
All these results are in a good agreement with those
obtained for the small one-histidine fragments as it was
demonstrated by Figure 4. The Hamiltonian parameters of the
[CuH-2L]
2@ species, obtained from ESR spectrum around physio-
logical pH are very similar to those belonging to Cu(II)@Tau(26-
33) and Cu(II)@Tau(Q26K-Q33K) systems at the same pH (Fig-
ure S10 in the Supporting Information). Also, the d-d band
value is coincident. In other words, a similar scenario in which
methionine sulphur atom coordinates Cu(II) in-plane turned out
again. Further deprotonation at higher pH values leads to the
formation of [CuH-3L]
3@ species where the amide nitrogen atom
replaces methionine coordination. The Hamiltonian parameters
are in line with a (Nim,N
@,N@,N@) coordination environment. It is
a common feature of multihistidine peptides that all imidazole
Table 4. Stability constants (logβpqr) and spectral data of the complexes
formed in the copper(II)@Ac@EDHAGTMHQD@NH2 system (T=298 K,
I=0.2 M KCl).
Species log βpqr Visible
spectra
CD
spectra
ESR spectra
λmax[ɛ] λmax[Δɛ] g j j A j j
[104×cm@1]
M/L 1 :1
[CuH2L]
2+ 16.77(5) – – – –
[CuHL]+ 12.24(6) – – – –
[CuL] 7.66(3) – – 2.295 176
[CuH-2L]
3@ @5.75(5) 590(75) 620
(@0.40)
504
(+0.08)
331
(+0.61)
297
(@0.15)
255
(+2.89)
2.217 195
[CuH-3L]
4@ @14.21(9) 564(90) 663
(+0.22)
567
(@0.62)
496
(+0.28)
357
(@0.02)
279
(+2.57)
2.204 208
M/L 2 :1
[Cu2H-3L]
2@ @7.18(5) – – – –
[Cu2H-4L]
3@ @14.38(11) – – 2.219 186
[Cu2H-5L]
4@ @22.67(15) – – 2.228 183
[Cu2H-6L]
5@ @32.12(15) 550(86) 642
(+0.49)
546
(@0.51)
492
(@0.43)
367
(@0.03)
308
(+0.96)
266
(+3.17)
2.196 204
log K
(Cu@2Nim)
7.66
pK12(amide) 6.71
pK3(amide) 8.47
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side chains can be independent metal binding sites resulting in
the formation of polynuclear complexes.[6,32] The potentiometric
and spectroscopic measurements performed in the presence of
excess metal ion support this expectation and provided direct
evidence for the formation of dinuclear complexes with the
decapeptide.
Table 4 and Figure 4.b show that the stoichiometry of the
dinuclear complexes varying from [Cu2H-3L]
@ to [Cu2H-6L]
4@
indicating that the involvement of amide nitrogen donors is
crucial for the formation of the dinuclear species. The high
complexity of the speciation curves does not allow the
determination of the exact spectral parameters for all dinuclear
complexes but the analysis of UV-vis, CD, ESR and mass spectra
(see below) provides a series of evidence for the existence of
dinuclear complexes.
In particular, the far-UV CD spectra of Cu(II)@Tau(12-16)(30-
34) at 2 : 1 metal to peptide ratio (Figure S9b), indicate that the
addition of one more equivalent of copper(II), in the pH range
7–10, resulted in a more-intense CD signal at λ=250 nm, similar
to the CD band observed in the Cu(II)@Tau(9-16) system,
suggesting the involvement of the His14 sites in the coordina-
tion of the second equivalent of copper(II).
Moreover, the bandwidth of the visible spectra measured
for 2 :1 system (Figure S11) is higher than it was measured for
the one-histidine fragments. This comes from the fact that the
absorption maxima of the fully deprotonated species ([CuH-3L])
are 530 nm for the Tau(9-16) peptide and around 560 nm for all
Tau(26-33) fragments. The corresponding value for the dinu-
clear complex ([Cu2H-6L]
4@) is 550 nm. Figure 5 is used to
compare the CD spectra of the above-mentioned species. It is
clear that the CD pattern of the dinuclear complex significantly
differ from the mononuclear ones but the superposition of
these spectra is in a very good agreement with that of the
measured spectra of the dinuclear species.
Finally, ESR spectra measured on frozen solutions of -copper
(II)@Ac@EDHAGTMHQD@NH2 system (metal-to-ligand ratio 2 :1)
showed a coordination of the two copper centers which is very
similar to those seen for metal-to-ligand ratio 1 :1, as the pH is
varied (Figure S12 in the Supporting Information). Of course, it
is not possible to distinguish among different isomers and the
parameters obtained can be considered as an average of the
very similar coordination environments formed at each pH
value.
High Resolution ESI-MS Analysis
Fourier Transform (FT-MS) and tandem mass spectrometry
investigations provided additional information regarding the
copper(II) interaction with Tau peptide fragments. The observa-
tion of mononuclear species, at 1 :1 metal-to-ligand ratio,
suggested the presence of one copper(II) binding site in the
Tau(9-16) and Tau(26-33) peptide fragments. Dinuclear species
can be also observed in the copper(II)@Tau(12-16)(30-34) system
at 2 :1 metal to peptide ratio (Figure S13).
HCD (High energy Collision Dissociation) of copper(II)
complexes, selected as precursor ions, was used to investigate
the metal@peptide interaction. Copper(II) complexes of Tau(9-
16), Tau(26-33) and Tau(12-16)(30-34) peptide fragments dis-
Figure 4. Concentration distribution curves of the major species formed in the copper(II)@Ac@EDHAGTMHQD@NH2 system, 1 :1 ratio (a), 2 : 1 ratio (b) (c(L)
=1 mM).
Figure 5. Visible CD spectra of the [CuH-3L]4@ complexes of Tau(9-16)
(Ac@EVMEDHAG@NH2) (1), Tau(Q26K-Q33K) (Ac@KGGYTMHK@NH2) (2),
[Cu2H-6L]
4@ of Ac@EDHAGTMHQD@NH2 (3) and superposition of CD spectra
of the [CuH-3L]
4@ complexes of Tau(9-16) and Tau(Q26K-Q33K) in 1 : 1 ratio
(4).
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sociated at CE lower than the respective apo@peptide frag-
ments (Table S2, see Supporting Information for more details).
This indicates that a metal ion induces fragmentation of peptide
complexes.[42] Comparison of the fragmentation pattern ob-
served in the MS/MS spectra, at collision energies (CE) needed
to start the precursor ion fragmentation, of the protonated
(Figure 6) and metal-bound peptides (Figure 7), provided inter-
esting information about the amino acid residues involved in
the copper(II) coordination. The principal fragments observed in
the apo@peptides (Figure 6) were generated by the cleavage of
amide bonds distributed along the entire peptide backbone
(see supporting information for more details).
On the other hand, HCD of the metal-bound peptides, low
collision energy conditions (Figure 7), produced primarily the bn
fragments obtained by the cleavage of peptide bond at the C-
terminal side of histidine residue. The cleavage of peptide bond
that occurred next to the metal@ion binding site was already
reported by the others.[43,44] A plausible mechanism was
suggested in Scheme S1 (see supporting information for more
details). Interestingly, the MS/MS spectra recorded for the -Cu
(II)@Tau(12-16)(30-34) system at 1 :1 metal to peptide ratio
(Figure 7) indicate that the peak corresponding to the Cu-b9
fragment was the principal fragment observed when the
mononuclear complex species started dissociation reaction at
CE 40. Therefore, dissociation of the His32@Gln33 amide bond is
favoured over dissociation of the His14@Ala15 bond suggesting
the copper(II) preference for binding to the His32 binding site. It
is important to note that the Cu-b3 fragment can also be
observed in the MS/MS spectra recorded at higher collision
energies (CE=50, Figure 7). Metal ion induced dissociation of
the His14@Ala15 bond may indicate a coordination mode where
both histidine side chains are involved in the copper complex-
ation as suggested by potentiometric results of the Cu(II)@-Tau
(12-16)(30-34) system at slightly acid pH values. When high CE
values are applied, the multi-histidine coordination mode can
be disrupted and the fragment formed in these conditions can
be rationalized on the basis of competitive binding of Cu(II)
between the histidine side chains. The formation of a multi-
histidine coordination mode can also justify the higher collision
energy needed to start the fragmentation of Cu(II)@Tau(12-16)
(30-34) (CE 40) in comparison with CE of Cu(II)@Tau(9-16) (CE
20) or Cu(II)@Tau(26-33) (CE 20) systems (Table S2).
The copper(II) preference for binding to the His32 binding
site was further supported by the MS/MS spectra of Cu(II)@-Tau
(9-16) and Cu(II)@Tau(26-33) precursor ions, recorded at high
collision energy (CE=50) (Figure S14). In particular, the compar-
ison of the spectra revealed a different fragmentation pattern
suggesting the involvement of Met31 side chain in the metal
coordination at the His32 binding (see the Supporting Informa-
tion for more details).
Conclusion
The studies reported in this manuscript give a comprehensive
view on the copper(II) binding ability of the N-terminal domain
of tau protein. Octapeptide fragments Tau(9-16)
(Ac@EVMEDHAG@NH2) including the His14 residue of the
protein and Tau(26-33) (Ac@QGGYTMHQK@NH2) including His32
site and some of its mutant have been first synthesized and
their copper(II)) complexes studied by the combined application
of solution equilibrium and various spectroscopic techniques
(UV-vis, CD, ESR, ESI-MS). Both fragments are able to bind
copper(II) ions. Histidyl residues are the primary metal binding
Figure 6. HCD spectra of single-charged peptides Tau(9-16) (m/z [M]+=928.38); Tau(26-33) (m/z [M]+=962.41) and Tau(12-16)(30-34) (m/z [M]+=1181.46).
Collision energies (CE) needed to start the precursor ion fragmentation were applied. The bn/an type fragment (blue color) and yn type fragments (red color)
produced through the cleavage of a bond in the peptide chain were also reported for each MS/MS spectrum.
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sites, but in the case of Tau(9-16) the side chain carboxylate
functions enhance the stability of the M@Nim coordinated
complexes. These species are present only in slightly acidic
solutions. Increase of pH results in the deprotonation and metal
ion coordination of the amide groups preceding the histidyl
sites. In the case of copper(II) the deprotonation of the first two
amide takes place in a cooperative manner which is a common
feature of the terminally protected peptides including internal
histidyl residues. This process results in the (Nim,N
@,N@) coordi-
nation mode and this is the predominating species in the
physiological pH range. Deprotonation and copper(II) coordina-
tion of the third amide group occurs under slightly alkaline
conditions. As a consequence, the donor atoms of the major
species in basic solutions are (Nim,N
@,N@,N@). The change of the
binding mode from the simple monodentate imidazole binding
to the amide bonded complexes changes the metal ion
preference of the two histidyl sites, as well. For the latter
binding mode His32 site predominates over His14. However,
taking into account the different pH ranges for the formation of
the corresponding copper(II) complexes His32 is the preferred
binding site for copper(II) at the physiological pH. This
preference in the metal binding of the histidyl sites remains
intact even if the two sequences are combined in a model
peptide. The decapeptide Ac@EDHAGTMHQD@NH2 contains
histidines in the same environments as in the native fragments.
The CD spectra give an unambiguous proof for the binding of
copper(II) to the second histidyl residue in alkaline samples
similar to the one-histidine counterpart. There are, however,
two major differences in the complex formation processes: the
decapeptide can keep two equivalents of copper(II) ions in
solution resulting in the formation of dinuclear complexes in
which the histidines are independent metal binding sites. It is
our opinion that the two imidazoles can form macrochelates
enhancing the overall metal binding ability of the decapeptide.
The results presented in this work may contribute to further
advance of our knowledge about the metal binding affinities of
the less studied N-terminal region of the tau protein.
Experimental Section
Materials
Solvents and chemicals used for synthetic purposes were obtained
from commercial sources in the highest available purity and
operated without further purification. The Rink Amide AM and
NovaSyn TGR resin, all of the N-fluorenylmethoxycarbonyl (Fmoc)-
protected amino acids (Fmoc@Gln(Trt)@OH, Fmoc@Asp(OtBu)@OH,
Fmoc@Glu(OtBu)@OH, Fmoc@His(Trt)@OH, Fmoc@Lys(Boc)@OH,
Fmoc@Met@OH, Fmoc@Thr(tBu)@OH, Fmoc@Tyr(tBu)@OH,
Fmoc@Ala@OH, Fmoc@Val@OH Fmoc@Gly@OH) and 2-(1-H-benzotria-
zol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU) were
purchased from Novabiochem (Switzerland). 2-methyl-2-butanol, N-
hydroxybenzotriazole hydrate (HOBt ·H2O), N-methyl-pyrrolidone
Figure 7. HCD spectra of single-charged copper complexes Cu(II)@Tau(9-16) (m/z [M]+=990.30), Cu(II)@Tau(26-33) (m/z [M]+=1024.33, Cu(II)@Tau(12-16)(30-
34) (m/z [M]+=1241.39) at CE 40 and CE 50. Collision energies (CE) needed to start the precursor ion fragmentation were applied. Only the metal bound bn/an
type fragment (blue color) and yn type fragments (red color), produced through the cleavage of a bond in the peptide chain, were indicated. The fragments in
green color correspond to an internal fragment.
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(NMP), 2,2’-(ethylenedioxy)diethanethiol (DODT), N,N,N’,N’-
Tetramethyl@O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate
and triisopropyl-silane (TIS) were purchased from Merck, while N,N-
diisopropylethylamine (DIPEA) and trifluoroacetic acid (TFA) were
Merck Millipore Co. products. Peptide-synthesis grade N,N-dimeth-
ylformamide (DMF) and acetic anhydride (Ac2O) were bought from
VWR International, while piperidine, dichloromethane (DCM), dieth-
yl ether (Et2O), acetic acid (AcOH) and acetonitrile (ACN) from Molar
Chemicals Ltd.
As concerns Cu(II) ions, stock solution (CuCl2) was prepared from
analytical grade reagents (Reanal) and its concentration was verified
gravimetrically via the precipitation of oxinate.
Peptide Synthesis
In the case of the investigated peptides solid phase peptide
synthesis was performed with the aid of a microwave-assisted
Liberty Peptide Synthesizer (CEM, Matthews, NC). Fmoc/tBu method
and TBTU/HOBt/DIPEA activation strategy were used. Cleaving of α-
amino protecting group of amino acids and resin was performed
with a 20 V/V% piperidine and 0.1 M HOBt ·H2O in DMF solution at
80 °C with 30 W microwave power for 180 s. Four times excess of
amino acids and 30 W microwave power for 300 s were used for
coupling at 80 °C in the presence of 0.5 M HOBt and 0.5 M TBTU in
DMF as an activator and 2 M DIPEA in NMP as an activator base.
The free amino terminus was treated with DMF containing 5 V/V%
Ac2O and 6 V/V% DIPEA to obtain the acetylated amino group. After
the finishing of synthesis, peptides were cleaved from their
respective resins, with the simultaneous removal of the side chain
protective groups, by treatment with a mixture of TFA/TIS/H2O in
94/2.5/2.5/1 V/V% or TFA/TIS/H2O 95/2.5/2.5 V/V% for 2 h at room
temperature. Each solution containing the free peptide was
separated from the resin by filtration. Cold Et2O was used to
precipitate the crude peptides from the solution and to wash from
the contaminants of the reagents of the synthesis and cleaving
agents. After filtering the product was dried under vacuum,
redissolved in water and lyophilized. The schematic structures of
the synthesized peptides are shown in Scheme 1.
The purity of the peptides (~90%) was checked by analytical RP-
HPLC and ESI-TOF and/or MALDI-TOF MS analysis, while the
protonation sites were identified by pH-potentiometric measure-
ments.
The purification of other peptides was carried out by preparative
reversed-phase HPLC using a Preparative scale-up LC-20A HPLC-
DAD system (Shimadzu) chromatography system with detection at
222 nm. To Ac@QGGYTMHQ@NH2, Ac@KGGYTMHK@NH2 and
Ac@EDHAGTMHQD@NH2 Synergi, Fusion-RP C18 250×10 mm (80 Å
pore size, 4 μm particle size), to Ac@KGGATMHK@NH2 Phenomenex,
Jupiter Proteo C12 250×4.6 mm (90 Å pore size, 4 mm particle
size), column were used. The peptides were eluted at a flow rate of
10 ml/min, where eluent was the mixture of solvent A (H2O
containing 0.1% TFA) and B (CH3CN containing 0.1% TFA) in
different percentage depending on pertinent method.
Potentiometric Measurements
pH-potentiometric titrations were completed on 3.00 mL samples
at 1–2 mM total ligand concentration with the aid of carbonate free
stock solution of potassium hydroxide of known concentration
(approximately 0.2 M). The metal to ligand ratios were selected
between 1 :1 and 2 :1. During titration, argon was bubbled through
the sample to ensure the absence of oxygen and carbon dioxide.
The samples were stirred using a VELP scientific magnetic stirrer.
All pH-potentiometric measurements were carried out at 298 K and
at constant ionic strength of 0.2 M KCl. pH measurements were
made with a MOLSPIN pH-meter equipped with a 6.0234.100 and
6.0234.110 combination glass electrode (Metrohm) and the titrant
was dosed by means of a MOL-ACS burette controlled by a
computer. During the titrations the following equilibrium condi-
tions were used: the system is in equilibrium if the maximum
change of potential is 0.03 mV for 9 seconds. The recorded pH
readings were converted into hydrogen ion concentration as
described by Irving et al..[45] Protonation constants of the ligands
and overall stability (logβpqr) constants of the metal complexes
were calculated by means of general computational programs
(PSEQUAD[46] and SUPERQUAD[47]) based on the [Equation (1) and
(2)].
p Mþ q Hþ r LMpHqLr (1)
bpqr ¼
MpHqLr
� �
M½ �p H½ �q L½ �r (2)
UV-Vis Spectroscopy
The same concentration range as used for pH-potentiometry was
selected to register the UV-vis spectra of the copper(II) complexes.
A Perkin Elmer Lambda 25 scanning spectrophotometer was
applied in the wavelength range of 250–900 nm.
Circular Dichroism (CD) Spectroscopy
A JASCO J-810 spectropolarimeter was used to perform the circular
dichroism (CD) measurements. CD spectra of the copper(II)
complexes were acquired from 220 to 800 nm using 1 cm and
Scheme 1. The structural formulae of peptides.
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1 mm cells and at the same concentration as applied for pH-
potentiometric measurements. Far UV-CD spectra were recorded
between 190–260 nm and the concentration of the ligand in the
sample changed between 0.15–0.20 mM.
Electron Spin Resonance (ESR) Spectroscopy
A Bruker Elexsys E500 CW-ESR spectrometer driven by a PC running
XEpr program under Linux and equipped with a Super-X microwave
bridge operating at 9.3–9.5 GHz, and a SHQE probe head was used
throughout this work. All frozen solution ESR spectra of copper(II)
complexes were recorded at 150 K by means of an ER4131VT
variable temperature apparatus. Copper(II)-peptide samples were
added of a small amount of methanol (up to 10%) in order to
increase spectral resolution. Parallel spin Hamiltonian parameters
were taken directly from the experimental spectra, always calculat-
ing them from the 2nd and 3rd line to get rid of errors coming from
second order effects.[48] An improved resolution of the ESR
spectra[37] was obtained with the use of isotopically pure 63Cu2+. In
order to achieve a better determination of the magnetic parame-
ters, some of the experimental spectra were simulated by the
program Monoclin[50,51] (which is able to discriminate one or more
species). Instrumental settings of frozen solution ESR spectra were
as follow: number of scans 2–10; microwave frequency 9.433–
9.437 GHz; modulation frequency 100 kHz; modulation amplitude
0.7 mT; time constant 163 ms; sweep time 2.8 min; microwave
power 20 mW; receiver gain 50–60 dB.
Mass Spectrometry
High-resolution (HR) ESI-MS spectra were recorded using Q Exactive
(Orbitrap) mass spectrometer (Thermo Fisher Scientific instruments)
in the same concentration range as used for Far-UV CD measure-
ments. Copper(II) complex solutions were introduced into the ESI
source on 100 mm internal diameter fused silica via a 500 ml
syringe. Full MS scans in the m/z range 200–2000 were acquired
with MS resolution of 150.000 FWHM (at m/z 400) in the Orbitrap.
Precursor ions of protonated peptides and metal bound peptides at
1 :1 metal-to-ligand ratio, were selected for Higher Energy Colli-
sional Dissociation (HCD) at different collision energies (CE). MS/MS
scans were acquired in the Orbitrap analyzer at 150.000 FWHM
resolution. The experimental conditions for spectra acquired in the
positive ion mode were: spray voltage=3.5 kV, capillary temper-
ature=250 °C; m/z range=200–2000, S-lens RF level=60 V, Sheath
gas=5. The molecular species were detected as clusters of peaks
because of the isotopic distribution of elements. The m/z values
indicated in the spectra correspond to most abundant ions of each
cluster.
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